WASHINGTON — Just a handful of Republicans have ever endorsed the progressive idea to let Medicare negotiate drug prices.
But now, less than five months since they were sworn in, two GOP lawmakers who defied party orthodoxy by campaigning on that plank already appear to have abandoned it.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- Online intelligence briefings
- Frequent opportunities to engage with veteran beat reporters and industry experts
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
About the Author Reprints
Open it up to any group including Medicare to negociate for better pricing. Why stop with one on this front when it is so important? Will it create issues? It might but we are a resilient people and we can face those as they come, for the moment the issue is high priced medication.
Looks like the 2 got a better deal from the drug industry . Hope the voters will remember at the next election !!!!!